Wesley Partridge, Sebastien A. Burel, Annie Ferng, Shuting Xia, T. Jesse Kwoh, Scott P. Henry, & Brenda F. Baker. (2023). Correlations between preclinical BJAB assay ranking of antisense drugs and clinical trial adverse events. Wiley.
Chicago Style (17th ed.) CitationWesley Partridge, Sebastien A. Burel, Annie Ferng, Shuting Xia, T. Jesse Kwoh, Scott P. Henry, and Brenda F. Baker. Correlations Between Preclinical BJAB Assay Ranking of Antisense Drugs and Clinical Trial Adverse Events. Wiley, 2023.
MLA (9th ed.) CitationWesley Partridge, et al. Correlations Between Preclinical BJAB Assay Ranking of Antisense Drugs and Clinical Trial Adverse Events. Wiley, 2023.
Warning: These citations may not always be 100% accurate.